Turkish Journal of Hematology Volume: 35 - Issue: 4

SUBJECT INDEX 2018
Gluteal lymphoma / Gluteal lenfoma, 310
Hematological malignancies / Hematolojik kanserler, 1
Hematopoietic cell transplant / Hematopoietik hücre
transplantasyonu, 152
Hematopoietic stem cell transplantation / Hematopoetik kök
hücre nakli, 27
Hemoglobin / Hemoglobin, 181
Hemophagocytosis / Hemofagositoz, 200
HER2 / HER2, 217
Hodgkin-like lymphoma / Folliküler lenfoma, 308
HyperCVAD regimen / HyperCVAD rejimi, 211
Ibrutinib / İbrutinib, 147
Immunophenotyping / İmmünfenotiplendirme, 94
Induced pluripotent stem cells / Uyarılmış pluripotent kök
hücreler, 260
Interleukin / İnterlökin, 301
Interleukin-10-1082A/G / İnterlökin-10-1082A/G, 99
Interleukin-2-330T/G / İnterlökin-2-330T/G, 99
Interleukin-6 / Interlökin-6, 283
Intravascular large B-cell lymphoma / İntravasküler büyük hücreli
lenfoma, 145
Invasive fungal infections / İnvazif mantar enfeksiyonları, 1, 277
Juvenile myelomonocytic leukemia / Juvenil myelomonositik
lösemi, 27
K562 / K562, 260
Kidney / Böbrek, 209
Late side effects / Geç yan etkiler, 87
Latency-associated peptide / Latent asosiye peptit, 116
Lymphoma / Lenfoma, 91, 197, 301
Lymphomatoid granulomatosis / Lenfomatoid granülomatozis, 213
Lymphoproliferative disease / Lenfoproliferatif hastalık, 200
Machine learning / Makine öğrenimi, 152
Mantle cell lymphoma / Mantle hücre lenfoma, 94
Mast cell leukemia / Mast hücre lösemi, 283
Mediastinal neoplasm / Mediastinal kitle, 141
Megakaryocytes / Megakaryosit, 150
Mesenchymal stromal cells / Mezenkimal stroma hücreleri, 19
Monoclonal gammopathy of unknown significance / Önemi
bilinmeyen monoklonal gammopati, 116
Monocytic differentiation / Monositik farklılaşma, 89
Multiple myeloma / Multipl myelom, 92, 116, 175, 271, 305
Multiple reinfusion days / Çoklu gün reinfüzyon, 271
Muscle lymphoma / Kas lenfoması, 310
Mutation analysis / Mutasyon analizi, 49
Mycosis fungoides / Mikozis fungoides, 35
Myelodysplastic syndrome / Myelodisplastik sendrom, 109, 283
Myelofibrosis / Myelofibrozis, 209
Myeloid sarcoma / Myeloid sarkom, 206
Myeloid-derived suppressor cells / Myeloid kökenli baskılayıcı
hücreler, 116
Myeloma / Myelom, 71, 150
New antifungal agents / Yeni anti-fungal ajanlar, 1
Non-Hodgkin lymphoma / Hodgkin dışı lenfoma, 73, 199
NPM1 / NPM1, 49
Orbita / Orbita, 92
Papilledema / Papilödem, 73
Paraplegia / Parapleji, 206
Pediatric hematologic malignancies / Pediatrik hematolojik
maligniteler, 87
PET/CT / PET/BT 175
PMBCL / PMBCL, 141
Polymorphism / Polimorfizm, 301
Posaconazole / Posaconazol, 277
Positron emission tomography/computed tomography /
Pozitron emisyon tomografi/bilgisayarlı tomografi, 175
Post-transplantation / Nakil sonrası, 313
Pyrosequencing / Pirodizileme, 49
Radiotheraphy and chemotherapy / Radyoterapi ve kemoterapi, 87
Real-time polymerase chain reaction / Gerçek zamanlı polimeraz zincir
reaksiyonu, 168
Recurrent bleeding / Tekrarlayan kanama, 305
Remission / Remisyon, 213
Revised International Prognostic Scoring System / Revize Uluslararası
Prognostik Skorlama Sistemi, 109
Rituximab / Ritüksimab, 312
rs1800896 / rs1800896, 99
rs2069762 / rs2069762, 99
Salivary flow rate / Tükürük akış hızı, 87
Sclerosing extramedullary hematopoietic tumor / Sklerozan
ekstramedüller hematopoetik tumor, 209
Sezary syndrome / Sezary sendromu, 35
Stem cell transplantation / Kök hücre nakli, 211
Stromal cell-derived factor 1α / Stromal hücre türevi factor-1α, 19
Teeth / Dişler, 87
Thalidomide / Talidomid, 305
Time to first treatment / İlk tedaviye kadar geçen zaman, 168